The use of liquid formulation pentoxifylline and vitamin E in both established and as a prophylaxis for dental extractions “at risk” of osteoradionecrosis-Reference-Cited by-同舟云学术

The use of liquid formulation pentoxifylline and vitamin E in both established and as a prophylaxis for dental extractions “at risk” of osteoradionecrosis

Published:2023-10 Issue:4 Volume:136 Page:404-409
ISSN:2212-4403
Container-title:Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
language:en
Short-container-title:Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Author:

Patel Vinod^ORCID,Young Helen,Mellor Amy,Sproat Chris,Kwok Jerry,Cape Angela,Mahendran Krishantini

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Dentistry (miscellaneous),Pathology and Forensic Medicine,Oral Surgery,Surgery

Reference33 articles.

1. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway;Delanian;Radiother Oncol,2004

2. Use of pentoxifylline and tocopherol in the management of osteoradionecrosis;Patel;Br J Oral Maxillofac Surg,2016

3. Pentoxifylline and tocopherol (vitamin E) with/without clodronate for the management of osteoradionecrosis: a scoping review;Banjar;Oral Dis,2023

4. Osteoradionecrosis—a review of current concepts in defining the extent of the disease and a new classification proposal;Lyons;Br J Oral Maxillofac Surg,2014

5. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial;Delanian;Int J Radiat Oncol Biol Phys,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pentoxifylline/Tocopherol-acetate;Reactions Weekly;2024-08-31

2. Prophylactic Use of Pentoxifylline and Tocopherol for Prevention of Osteoradionecrosis of the Jaw after Dental Extraction in Post-Radiated Oral and Oropharyngeal Cancer Patients: An Initial Case Series;Dentistry Journal;2024-03-22

3. The use of pentoxifylline within the medical regime for the management and prevention of osteoradionecrosis in patients with cardiac‐, cerebrovascular and thromboembolic conditions;Oral Surgery;2024-01-03

4. The management of osteoradionecrosis in palliative head and neck cancer patients;Oral Surgery;2024-01